Department of Epidemiology, University of Iowa, Iowa City, IA, United States.
Department of Epidemiology, University of Iowa, Iowa City, IA, United States; Department of Pediatrics, University of Iowa, Iowa City, IA, United States.
Pregnancy Hypertens. 2022 Aug;29:101-107. doi: 10.1016/j.preghy.2022.07.002. Epub 2022 Jul 6.
Hypertension during pregnancy can adversely affect maternal and fetal health. This study assessed whether diagnosis of leukemia or lymphoma prior to pregnancy is associated with hypertensive disorders of pregnancy including gestational hypertension, preeclampsia and eclampsia.
A cross-sectional study used two statewide population-based datasets that linked birth certificates with sources of maternal medical history: hospital discharges in California and Surveillance, Epidemiology, and End Results (SEER) cancer registry data in Iowa. Birth years included 2007-2012 in California and 1989-2018 in Iowa.
Primary outcome measure was hypertension in pregnancy measured from combined birth certificate and hospital diagnoses in California (for gestational hypertension, preeclampsia, or eclampsia) and birth certificate information (gestational hypertension or eclampsia) in Iowa.
After adjusting for maternal age, race, education, smoking, and plurality, those with a history of leukemia/lymphoma were at increased risk of hypertensive disorders of pregnancy in Iowa (odds ratio (OR) = 1.86; 95% CI 1.07-3.23), but not in California (OR = 1.12; 95% CI 0.87-1.43). In sensitivity analysis restricting to more severe forms of hypertension in pregnancy (preeclampsia and eclampsia) in the California cohort, the effect estimate increased (OR = 1.29; 95% CI 0.96-1.74).
In a population-based linked cancer registry-birth certificate study, an increased risk of hypertensive disorders of pregnancy was observed among leukemia or lymphoma survivors. Findings were consistent but non-significant in a second, more ethnically diverse study population with less precise cancer history data. Improved monitoring and surveillance may be warranted for leukemia or lymphoma survivors throughout their pregnancies.
孕期高血压会对母婴健康造成不良影响。本研究评估了孕前诊断出白血病或淋巴瘤是否与妊娠高血压疾病(包括妊娠期高血压、子痫前期和子痫)有关。
这是一项使用两个全州范围内基于人群的数据集的横断面研究,将出生证明与母亲病史来源相联系:加利福尼亚州的医院出院记录和爱荷华州的监测、流行病学和最终结果(SEER)癌症登记数据。出生年份包括加利福尼亚州的 2007-2012 年和爱荷华州的 1989-2018 年。
主要结局指标是加利福尼亚州通过出生证明和医院诊断(用于妊娠期高血压、子痫前期或子痫)以及爱荷华州通过出生证明信息(妊娠期高血压或子痫)测量的妊娠高血压;加利福尼亚州的妊娠期高血压疾病(妊娠期高血压或子痫)。
在校正了母亲的年龄、种族、教育程度、吸烟状况和多胎妊娠后,有白血病/淋巴瘤病史的人在爱荷华州发生妊娠高血压疾病的风险增加(比值比(OR)=1.86;95%置信区间 1.07-3.23),但在加利福尼亚州没有(OR=1.12;95%置信区间 0.87-1.43)。在加利福尼亚州队列中,对妊娠高血压疾病(子痫前期和子痫)更严重形式进行敏感性分析时,效应估计值增加(OR=1.29;95%置信区间 0.96-1.74)。
在一项基于人群的癌症登记-出生证明研究中,白血病或淋巴瘤幸存者发生妊娠高血压疾病的风险增加。在第二个研究人群中,观察到的结果一致但无统计学意义,该人群的种族更多样化,癌症病史数据不那么精确。可能需要对白血病或淋巴瘤幸存者在整个孕期进行更密切的监测和监测。